John P. Oshea is Director at AOXING PHARMACEUTICAL COMPANY, INC. (AXN). They have made 13 open-market trades across 4 companies since 2006, most recently 2022-08-31.
CIK 0001139589
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
8 open-market purchases totalling $611K since 2009, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| STQN | SELL | 2022-08-31 | 2022-09-02 | $0.06 | $27K | N/A | N/A | N/A |
| STQN | SELL | 2018-04-24 | 2018-04-26 | $0.40 | $10K | N/A | N/A | N/A |
| STQN | SELL | 2017-10-19 | 2017-10-20 | $0.40 | $300K | N/A | N/A | N/A |
| STQN | SELL | 2016-12-30 | 2017-01-05 | $0.40 | $50K | N/A | N/A | N/A |
| STQN | BUY | 2016-03-01 | 2016-03-02 | $0.40 | $10K | N/A | N/A | N/A |
| STQN | BUY | 2015-03-19 | 2015-03-23 | $0.40 | $10K | N/A | N/A | N/A |
| STQN | BUY | 2013-02-25 | 2013-02-26 | $0.25 | $20K | N/A | N/A | N/A |
| STQN | BUY | 2011-03-21 | 2011-03-21 | $0.25 | $17K | N/A | N/A | N/A |
| AXN | BUY | 2011-01-19 | 2011-01-20 | $2.59 | $19K | N/A | N/A | N/A |
| STQN | BUY | 2010-07-30 | 2010-08-02 | $0.20 | $77K | N/A | N/A | N/A |
| CAXG | BUY | 2009-10-06 | 2010-01-20 | $0.97 | $47K | N/A | N/A | N/A |
| CAXG | BUY | 2009-08-06 | 2009-08-07 | $0.95 | $411K | N/A | N/A | N/A |
| [FRANKLYN] | SELL | 2006-06-02 | 2006-09-25 | $0.06 | $60K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.